Manuela Polydoro

Manuela has more than 10 years of experience in neurodegeneration research, drug discovery, and development in pharma and biotech.

Prior to joining Muna, she led and managed cross-functional teams developing treatments for neurodegenerative and neuromuscular diseases at Novartis, Amgen and startup biotech companies.